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(EM) of iachemic origin and patients w%h idiopathic DCM. This study included 93 patients regurgitation improved by biventricular pacing in these patients with severe heart failure, 
consecuttvefy implanted with a Biventricular pacemaker between August 1994 and February atrial fibrillation and intraventricular conduction delay. 
2C00. Patients were retrospectively divtdsd into two groups (idiopathic and ischemic) accord- 
ing to the results of a recent coronary angiogram. Symptoms and objective data were 
Rand BIV 9M BIV 12M 
assessed before PM implant (pre-I) and 6 months (M-6) after. within the 2 groups. Results 
are summarized in this table : 
Conclusion : Permanent Biventrtcular pacing provides significant and sustained improvement 
in symptoms, exercise tolerance and LVEF in both idiopathtc and ischemic DCM patients. 
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078-2 influence of Antitachy Pacing Location on the Efficacy 
of Ventricular Tachycardia Termination 
&~&&ef, Barbara Lamp, Johannes Heintze, Bert Hansky, Juergen Vogt. Frank 
Warzok, Berthold Kramm, Reiner Koerfer, Dieter Horstkotte, Hear-f Center North Rhine- 
Westphalia, Bad Oeynhausen, Germany Bakken Research Center. Maastricht, Belgium. 
Background: Biventdcular (BV) pacing is an important treatment option in patients (pts) with 
severe heart failure (HF). ICD-implantation with BV pacing is expected to help managing the 
dsk of malignant tachyarrhythmias in this population. 
Methods: The InSync ICD is a combined ICD and BV pacemaker with dual chamber detection 
and flexibte ATP programming. The InSync ICD study enrolled 81 patients with severe HF 
(93% male, 64t9 y, CAD 56%, LVEF 25+7% LVEDD 7lallmm and NYHA 2.6&6). Inclusion 
cdterta were NYHA II-IV, LVEF<35%, LVEDD>55mm and ICD indication. ICDs were randomly 
programmed to right-ventricular (RV)-ATP or BV-ATP. The VT termination efficacy and VT 
acceleration was evaluated for both padng locations and for VT cycle length (CL). 
Results: 457 spontaneous VT episodes cccurred in 26 pts. 17 pts were programmed to RV- 
ATP, 9 patients to BV-ATP. Overall ATP efficacy was 64%, with 75% for RV-ATP and 91% for 
BV-ATP. Mean VT cycle length was significantly shorter for RV-ATP (369ms YS 369ms). After 
calculation for VTCL and initial therapy using logistic regression termination efficacy remained 
signiffcantty ( 2.4 times ) higher with BV-ATP. 
Condusion: BV-ATP in this limited population appears to be more effective in VTiFVT termina- 
tion and may reduce the number of VTIFVT accelerations. 
Spontaneous Episode ATP Therapy Efficacy (FvTcFast VT Zone; vT=vT Zone) 
ATP Site 
RV 
BV 
Detection #Episodes 
FVT 50 
VT 154 
VTNFT 204 
FVT 57 
VT 170 
VTIFVT 227 
terminated 
31 (62%) 
123 (60%) 
154 (75%) 
43 (75%) 
163 (96%) 
206 (91%) 
accelerated 
15 (30%) 
5(5%) 
23 (11%) 
9 (16%) 
3 (2%) 
12 (5%) 
430 p.m. 
LVEDD (mm) 
LVESD (mm) 
MR area (cmz) 
DFf 
“=67 n=32 n=29 
7M9 66flO 66i6 
6ltlO 57fll 58i5 
10.6f13.7 6.4k6.2 5.4zt3.9’ 
346C99 357*133 405?143# 
M=months, #p=O.O6, ‘~~0.05, all compared to baseline 
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878-4 Can the Optimum Dosage of Resynchronization 
Therapy be Derived From the intracardiac Eiectrogram? 
Angelo Auricchio, Andrew Kramer, Julio C. E&(6&. Jiang Ding, Yinghong Yu, Walter 
Hoersch, Christian Butter, Christoph Stellbrink, PATH CHF I & II investigator groups, 
Universify Hospital, Magdeburg, Aachen, Berlin, Germany, Guidant CRM, St. Paul, 
Minnesota. 
We tested the hypothesis that the degree of pre-excitation required to provide optimum 
resynchronization can be predicted from the intrinsic atrioventricular (AV) interval. Meth- 
ods: We tested 117 patients (NYHA class II-IV, EF c 30%) in the PATH CHF studies. 99 
tests in 60 patients were used in the development data set (DST) and 50 tests/37 pro- 
spective patients constitute the test data set (TST). Intrinsic AV intervals were measured 
from the atrial event to the earliest peak in the ventricular leads. Linear regression coeffi- 
cients between the AV delay that provided optimum dP/dt,, and the measured intrinsic 
AV interval were separately calculated for the cases with QRS>lSO ms 8 QRSs150 ms 
in the DST. Using these coefficients we calculated the estimated optimum AV delay for 
the cases in the TST and for all cases. The improvement in dP/dt,,, at actual optimum 
AV delay (dP/dt,& was compared with the improvement in dP/dt,,, obtained at the esti- 
mated optimum AV delay (dP/d&) both for the patients in the TST and for the entire 
population. Results: For the patients in the TST group dP/d&=.99’dP/dL,“t-1.75 
(&0.96, pcO.0001; M.03 p<O.oOOl, and i0.43 p=O.O002 respectively). For the entire 
population, depicted in the Figure, dP/d& 1 .Ol’dP/d&,-2.19 (&0.97, pc0.0001; 
to.01 and 10.26 respectively, p<O.OOOl). Conclusion: The AV delay that provides opti- 
mum dP/dt,,, can be reliably predicted from the intrinsic AV interval. 
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870-3 Reverse Mechanical Remodeling by Biventricuiar 
Pacing in Congestive Heart Failure: One-Year Results 
From Patients in Atrial Fibrillation in the MUSTIC 
Events 
Wednesday, March 20, 2002, 8:30 a.m.-10:OO a.m. 
Georgia World Congress Center, Room 257W 
(MUltisite STimuiation in Cardiomyopathy) Study 
Cecilia Linde, Christoohe Leclerco, Serae Cazeau, Lukas KaDDenbemer, Richard Sutton, 
8:30 a.m. 
Christophe Bailleul, Jean-Claude, on behalf of the MUSTIC Study Group, 
Karolinska Hospital, Stockholm, Sweden. 
Background: The MUSTIC study is a controlled multicenter trial, to assess the clinical 
efficacy of biventdcular pacing @IV) in patients with chronic NYHA ill heart failure and 
intrinsic QRS >150 or RV paced QRS >200 ms. We recently reported symptomatic relief 
from the crossover phase (CO) with progressive improvements over a year. The aim of 
this study was to assess if left ventricular function improves over time in the group of 
patients with atrial fibrillation (AF) and slow ventricular rate either due to spontaneous 
rhythm or His-ablation. 
Methods: Of 64 included patients 39 completed the 6 month CO single blind comparison 
of BIV and no-BIV excluding two patients who due to fast AF were not BIV paced. Of 
these 35 preferred and were programmed to BIV and followed longitudinally by clinical 
parameters, Doppler echocardiography and left ventricular (LV) ejection fraction mea- 
sured by radionucleides. 
Results: LV ejection fraction increased from 26.7 * 6.6 % at randomisation (rand) to 30.4 
i: 7.6 % after 1 year of BIV (p<O.O5). LV function by Doppler echo i.e. diastolic filling time 
(DFT), left ventricular enddiastolic and systolic diameters (LVEDD, LVESD) and mitral 
regurgitation (MR) are given in the Figure. 
Conclusion: In parallel with clinical benefits, left ventricular ejection fraction and mitral 
884-l Value of Immediate Postoperative Electrocardiogram to 
Readjust Risk Stratification of Patients Undergoing 
Major Noncardiac Surgery 
sRinfret. Carisi A. Polanczyk. Thomas H. Lee, Brigham and Women’s Hospital, 
Boston, Massachusetts, Centre Hospitalier de I’Universite de Montreal, Hopitsl Notre- 
Dame, Montreal, Quebec, Canada. 
Background: Despite preoperative stratification, additional information collected shortly 
after major non-cardiac (NC) surgery might help to reassess risk of major cardiac compli- 
cations (MCC) and guide therapy. The usefulness of a simple electrocardiogram (ECG) 
performed in the recovery room is unknown. 
Methods: Between 07169 and OZ94, perioperative data and outcomes were collected on 
4315 patients who underwent major NC procedures at Brigham end Woman’s Hospital. 
From this cohort, 3622 (63.9%) patients had an ECG performed in the recovery room. 
Results: Univariate analysis showed a higher incidence of MCC (myocardial infarction, 
pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart 
block) in patients with signs of ischemia (ST depression or elevation, or T wave abnor- 
malities) on the immediate postoperative (PO) ECG compared to those without ischemia 
(6.7 VS. 1.9%, p<O.OOl). Patients who presented signs of ischemia on PO ECG were 
older, more likely to be diabetic and treated with insulin, had a higher prevalence of coro- 
nary artery peripheral, or cerebrovascular disease, hypertension, congestive heart fail- 
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we, elevated serum creatinine, preoperative ECG ischemic abnormalities or signs of 
hypertrophy, positive stress test, and had a worse functional StatuS. all risk factors of 
MCC in that cohort (all p < 0.05). Using mUltipIe logistic regression analysis. Signs Of 
ischemia on the immediate PO ECG remained an independent predictor of MCC (Odds 
Ratio (O&1.6; 95% Confidence Interval (CI)=l.O-3.3, p&05). Furthermore. stratifica- 
tion by initial Revised Cardiac index showed that despite lower preoperative risk assess- 
ment (Class I-II). presence of ischemia on the immediate PO ECG identified a subgroup 
of patient with higher risk of MCC (O&4.2. 95%CI=1.4-12.6). In class III-IV patients, PO 
ischemia was also associated with higher incidence of MCC (OR=2.0, 95%Cl=l.l-3.6). 
Conclusion: Signs of ischemla on the immediate PO ECG were associated with higher 
MCC rate, even in patients stratified at low risk preoperatlvely. These results argue for 
routine performance of the ECG in the recovery room following major NC surgery. 
a:45 a.m. 
884-2 Time to Relapse of Atrial Fibrillation and Signal- 
Averaged P Wave Duration 
uDlxen, Jan Pamer, Vemer Rasmussen, Steen M. Pehrson, Gorm B. Jensen, The 
University Hospital of /fvidovre, Copenhagen, Denmark. 
Background: Prolonged Signal-Averaged P Wave Duration (SAPD) has been established 
as a risk marker for atrial fibrillation. We assessed the time to first symptomatic atrial 
fibrillation relapse in patients with earlier or present atrial fibrillation in relation to the 
SAPD, clinical characteristics of the patients, and the duration of the atrial fibrillation dis- 
ease. 
Methods-111 consecutive patients (71/40 men/women; median age 65 years, range 30- 
65 years) with earlier or acute atrial fibrillation were enrolled. Patients undergoing elec- 
tive cardioversion of long-lasting atrial fibrillation during the inclusion period were not 
included. The SAPD was measured at inclusion, and the follow-up time was six months 
(median 164 days; range 171-437 days). The time to first relapse of atrial fibrillation was 
regarded as endpoint treating deaths without atria1 fibrillation and patients without 
relapse during follow-up as censorings. 
Results- During follow-up 50 patients had a symptomatic attack of atrial fibrillation. Pro- 
portional hazard regression analysis showed a significant effect of moderately prolonged 
SAPD 135145 ms (hazard ratio 3.31, Cl 1.47.7.46), of severely prolonged SAPD above 
145 ms (hazard ratio 2.74, Cl 1.23-6.12), a common p value of 0.005, and of longer total 
duration of the atrial fibrillation disease than two years (hazard ratio 2.06, Cl 1.13-3.75, 
p=O.O2). We found no predictive effect of age, gender, diagnosed hypertension, the left 
atrial diameter or low ejection fraction. 
Conclusions: Risk factors for early atrial fibrillation relapse were prolonged signal-aver- 
aged P wave duration above 135 ins, and a total duration of atria1 fibrillation disease 
longer than two years. 
9:00 a.m. 
884-3 Ventricular Gradient Is an Independent Risk Factor in 
Survivors of Acute Myocardial Infarction 
y.&J& N. Batchvu, Katerina Hnatkova, Azad Ghuran, Jan Poloniecki, Peter 
Smetana, A John Camm, Marek Malik, StGeoge’s Hospifal Medical School, London, 
United Kingdom. 
Ventricular gradient (VG) reflects inhomogeneity of ventricular repolarisation. Its relation to 
prognosis in myocardiil infarction (Ml) is unknown. We examined multivariately the link 
between an optimised version of VG (TCRT, angular difference between spatial QRS and T 
vectors) and cardiac mortality in survivors of acute Ml. 
Methods: Age, left ventricular ejection fraction (EF), QRS duration on signal-averaged ECG 
(SAECG), ventricular ectopicshour, mean RR interval, heart rate variability (HRV) index, 
heari rate turbulence slope on 24.hour Halter, and TCRT (calculated from averaged XYZ 
leads of the SAECGs) were measured before discharge in 1047 Ml survivors (age 58*9 
years, 61% men). During a follow-up censored at 5 years, 124 (12%) cardiac deaths 
occurred. All parameters were dichotomised by the percentile separating 20% of pts with 
the most risk-associated values. 
Results: EFc33% (relative risk (RR) 2.9, 95%CI: 1.4-5.6, psO.003) and TCRT<-0.66 (RR 
3.4, Cl 1.6-6.4. p=O.O002) were independent predictors of 5year cardiac mortality, while 
HRV tndexl6.3U (RR 3.6, Cl 1.2-11.3. p=O.O3) and TCRTc-O.66 (RR 2.9, Cl 1.2. 
7.1 .p=O.O2) were independent predictors of 1 -year cardiac mortality.Five-year cardiac mor- 
tality in pts with both EF>33% and TCRT>-0.66 was appr. 6%, in pts with either EF<33% or 
TCRT<-0.68 it was appr.l6%. and in pts with both EF<33% and TCRTc-0.66 it was >50% 
(Figure). 
Conclusions: Decreased TCRT (‘optimised’ VG) is an independent predictor of cardiac 
death in survivors of acute MI. 
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884-4 Does Atrial Electrlcal Function in Patients With Atrial 
Flutter Recover? 
m, Hidekazu Hirao, Sou Takenaka, Yukiko Nakano, Kentaro Ueda. Kenya 
Sakai. Keiji Matsuda. Yukihiro Fukuda, Hiroki Teragawa, Togo Yamagata. Hideo 
Matsuura. Kazuaki Chayama, First Department of Internal Medicine, Hiroshima 
University School of Medicine, Hiroshima, Japan. 
Background: The P wave signal-averaged electrocardiogram (PSAE) has been clinically 
applied to detect patients with paroxysmal atrial fibrillation. However, little is known about 
patients with atria1 flutter (AFL). We analyzed PSAE of patients after successful catheter 
ablation for AFL to determine whether atrial electrical function in patients with AFL 
recover. 
Methods: The study group consisted of 10 patients undergoing ablation of chronic coun- 
terclockwise typical AFL. The flutter cycle length was 251*7ms. The patients had docu- 
mented AFL for 2lfl7months. The control group consisted of 20 patients without any 
arrhythmias. Ablation was performed by creating a linear lesion between the tricuspid 
annulus and inferior vena cava. AFL ablation end point was bidirectional isthmus block. 
PSAE was recorded 1 day, 7 days and 1 month after the ablation. We measured the fil- 
tered P wave duration (PD) and the root mean voltage (LP20, LP30) for the terminal 20 
and 30 ms of the filtered P wave. 
Results: All patients were no recurrence of AFL for 1 month after the ablation. The PD 
was significantly prolonged in patients with AFL at lday after the ablation compared with 
control group (161i17 vs. 134?llms, p=O.O003). LP20 and LP30 were lower in patients 
with AFL than those in control group (1.4fo.5 vs. 2.011.OpV; 1.9fo.2 vs. 3.0+1.6lV, 
respectively). PD was 161+17, 156f30 and 146k21ms; LP20 was 1.4m.5, 2.0x).7 and 
3.0*1 .OFV; LP30 was 1.9fl.2, 2.6i0.7 and 3.7+1.2pV at 1 day, 7 day and 1 month after 
the ablation. LP20 and LP30 were greater at 1 month than those at 1 day (p=O.O02, 
p=O.OOl) 
Conclusion: The findings of this study showed: 1) The PD was significantly prolonged in 
patients with AFL. And this prolongation was improved for 1 month after the ablation; 2) 
LP20 and LP30 were greater in 1 month after the ablation than those in 1 day. These 
findings suggest that atrial electrical dysfunction in patients with AFL recover for 1 month 
after the ablation. Catheter ablation for AFL can improve the electrical substrate of atrial 
fibrillation in patients with atrial fibrillation/flutter. PSAE may be clinical use to distinguish 
the patients with recurrence of AFL or atrial fibrillation from those without recurrence. 
930 a.m. 
884-5 Deficits in Knowledge Related to the OT Interval That 
Could Impact Patient Safety 
mM. Sana M. Al-Khatib, Judith M. Kramer, Judy Battle, Robert M. 
Califf. Duke Clinical Research Institute, Durham, North Carolina. 
Background: Several medications have recently been removed from the US drug market 
because of QT-interval (QTI) prolongation and torsade de pointes. Despite labeling 
changes and warnings to attempt to reduce inappropriate use of these agents and mini- 
mize the risk of torsade de pointes, inappropriate prescribing continued to occur. Since 
many other QTI-prolonging medications remain on the market, we conducted an evalua- 
tion of practitioner knowledge of the QTI and medications that may cause QTI- prolonga- 
tion to determine if knowledge deficits exist that could partially explain the inappropriate 
use of these agents in clinical practice. 
Methods: Practitioners were surveyed at a cardiology symposium in November 2000 and 
a meeting of cardiology investigators in February 2001. The number and percentage of 
practitioners who correctly answered questions related to the QTI were detenined. 
Results: A total of 334 respondents completed the survey [127 (36%) physicians, 149 
(45%) nurses, 30(9%) physicians in training, 16(5%) unspecified, 5(2%) study coordina- 
tors, 4 (1%) physician assistants, and 3 (0.9%) pharmacists]. Cardiology was the area of 
specialization for 271 (61%) of the respondents. Eighty-six percent of respondents stated 
that they would measure a QTI before and after starting a QT prolonging medication. 
Sixty-one percent were able to identify what the QTI represented on an EKG, but only 
36% ware able to measure a QTI Twenty percent were able to identify causes of QTI 
prolongation, and 7% were able to identify patient factors associated with increased risk 
of torsade de pointes. Less than 1% of respondents were able to correctly identify drugs 
that prolong the QTI or drug combinations that prolong the QTI. 
Conclusion: Although most cardiology practitioners said that they measured the QTI 
when starting a QTI-prolonging medication, this survey indicated marked deficiencies in 
their ability to correctly measure the QTI and to identify patient factors and medications 
associated with QTI prolongation. This study demonstrates the need to improve practitio- 
ners knowledge on this important patient safety issue 
9:45 a.m. 
884-6 Prolonged PR Interval Is Associated With increased 
Risk of Atrial Fibrillation: The Framingham Heart Study 
Vasan Marlin G. Larson, Daniel Levy, Eric P. Leip, Ralph B. 1 
D’Agostino, Sr., Philip A. Wolf, William B. Kannel, Emelia J. Benjamin, NHLBl’s 
Framingham Heart Sfudv, Framingham, Massachusetts, Boston University School Of 
Medicine, Boston, Massachuseffs. 
Background: P wave prolongation on the ECG is associated tith increased risk of atrial 
fibrillation (AF). The PR interval is an easily measured marker of atrial and atrioventricu- 
lar conduction. We hypothesized that prolonged PR interval may be associated with 
increased risk of AF. 
Methods: We examined the association ot PR interval, measured with digital calipers on 
